Literature DB >> 22944080

Multiple synchronous early gastric cancers: high-risk group and proper management.

In Seob Lee1, Young Soo Park, Kab Choong Kim, Tae Hwan Kim, Hee Sung Kim, Kee Don Choi, Gin Hyug Lee, Jeong Hwan Yook, Sung Tae Oh, Byung Sik Kim.   

Abstract

BACKGROUND: Multiple early gastric cancers (MEGCs) may be easily missed on preoperative gastroscopy because the lesions are predominantly small and flat. This may increase the risks of gastric remnant lesions and recurrence. We aimed to define high-risk group of MEGC and suggest proper management of missed lesion after partial gastrectomy.
METHODS: A total of 117 patients with MEGCs and 2182 with solitary EGC who underwent gastrectomy between 2008 and 2010 were retrospectively analyzed to determine their clinicopathologic characteristics. We also assessed their family history, the presence of Helicobacter pylori infection, and of precancerous lesions; and the results of microsatellite instability and immunohistochemical staining of the primary (largest) lesion for p53, human epidermal growth factor receptor [HER1], and HER2 were also reviewed.
RESULTS: MEGCs occurred more frequently in elderly males and in patients with adenoma, atrophic gastritis, or a family history of gastric cancer. These patients had more favorable pathologic findings, including less deep invasion, better differentiation, more intestinal type, and less frequent lymphovascular/perineural invasion than patients with solitary EGCs. The mean size of MEGCs was smaller (2.44 cm vs 3.36 cm) but there was no difference in the number of metastatic lymph nodes. Most accessory lesions were confined to the mucosal layer, with their average diameter was 1.82 cm.
CONCLUSIONS: A careful preoperative gastroscopy should be performed in patients at high risk of MEGCs and more cautious postoperative endoscopic surveillance of the remnant stomach is required. For missed foci on remnant stomach, endoscopic resection can be a good option if it meets the criteria.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22944080     DOI: 10.1016/j.suronc.2012.08.001

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  6 in total

1.  Seven synchronous early gastric cancer with 28 lymph nodes metastasis.

Authors:  Hyeonjin Seong; Jin Il Kim; Hyun Jeong Lee; Hyun Jin Kim; Hyung Joon Cho; Hye Kang Kim; Dae Young Cheung; Dong Jin Kim; Wook Kim; Tae-Jung Kim
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

2.  Incidence of metachronous gastric cancer in the remnant stomach after synchronous multiple cancer surgery.

Authors:  Isao Nozaki; Shinji Hato; Takaya Kobatake; Koji Ohta; Yoshirou Kubo; Rieko Nishimura; Akira Kurita
Journal:  Gastric Cancer       Date:  2013-04-27       Impact factor: 7.370

3.  Risk factors for submucosal and lymphovascular invasion in gastric cancer looking indicative for endoscopic submucosal dissection.

Authors:  Takeshi Yamada; Hiroaki Sugiyama; Daisuke Ochi; Daisuke Akutsu; Hideo Suzuki; Toshiaki Narasaka; Toshikazu Moriwaki; Shinji Endo; Tsuyoshi Kaneko; Kaishi Satomi; Kazuto Ikezawa; Yuji Mizokami; Ichinosuke Hyodo
Journal:  Gastric Cancer       Date:  2013-12-10       Impact factor: 7.370

4.  Risk Factors for Metachronous Gastric Neoplasms in Patients Who Underwent Endoscopic Resection of a Gastric Neoplasm.

Authors:  Hyuk Yoon; Nayoung Kim; Cheol Min Shin; Hye Seung Lee; Bo Kyoung Kim; Gyeong Hoon Kang; Jung Mogg Kim; Joo Sung Kim; Dong Ho Lee; Hyun Chae Jung
Journal:  Gut Liver       Date:  2016-03       Impact factor: 4.519

5.  Predictive risk factors associated with synchronous multiple early gastric cancer.

Authors:  Seok Hoo Jeong; Jungsuk An; Kwang An Kwon; Woon Kee Lee; Kyoung Oh Kim; Jun-Won Chung; Yoon Jae Kim; Dong Kyun Park; Jung Ho Kim
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

6.  High Expression of Claudin-4 Is Associated with Synchronous Tumors in Patients with Early Gastric Cancer.

Authors:  Won Shik Kim; Hayeon Kim; Moon Kyung Joo; Byung Il Choi; Ah Young Yoo; Jong-Jae Park; Beom Jae Lee; Seung Han Kim; Hoon Jai Chun
Journal:  J Clin Med       Date:  2022-06-20       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.